广告Reduce The Risk Of Sustained eGFR Decline In CKD in T2D Patients With A Once-Daily Pill. Reduce Risk Of End-Stage Kidney Disease In Your CKD in T2D Patients With A Treatment.
Savings and Support · Clinical Efficacy · Prescribing Information · Contact a Representative